Ischemia and reperfusion may cause liver injury and are characterized by hepatic microperfusion failure and a decreased hepatocellular function. Inhibition of
glycogen synthase kinase (GSK)-3β, a
serine-threonine kinase that has recently emerged as a key regulator in the modulation of the inflammatory response after stress events, may be protective in conditions like
sepsis,
inflammation and
shock. Therefore, aim of the study was to assess the role of GSK-3β in liver microcirculation and hepatocellular function after
hemorrhagic shock and
resuscitation (H/R). Anesthetized male Sprague-Dawley rats underwent pretreatment with Ringer´s
solution, vehicle (
DMSO) or
TDZD-8 (1 mg/kg), a selective GSK-3β inhibitor, 30 min before induction of
hemorrhagic shock (mean arterial pressure 35±5 mmHg for 90 min) and were resuscitated with shed blood and Ringer´s
solution (2h). 5h after
resuscitation hepatic microcirculation was assessed by intravital microscopy.
Propidium iodide (PI) positive cells, liver
enzymes and alpha-GST were measured as indicators of hepatic injury. Liver function was estimated by assessment of
indocyanine green plasma disappearance rate. H/R led to a significant decrease in sinusoidal diameters and impairment of liver function compared to
sham operation. Furthermore, the number of PI positive cells in the liver as well as serum activities of liver
enzymes and alpha-GST increased significantly after H/R. Pretreatment with
TDZD-8 prevented the changes in liver microcirculation, hepatocellular injury and liver function after H/R. A significant rise in the plasma level of
IL-10 was observed. Thus, inhibition of GSK-3β before
hemorrhagic shock modulates the inflammatory response and improves hepatic microcirculation and hepatocellular function.